Literature DB >> 8705672

Determination of natural killer cell function by flow cytometry.

K L Kane1, F A Ashton, J L Schmitz, J D Folds.   

Abstract

Natural killer cells (NK cells) are a subset of peripheral blood lymphocytes that mediate non-major histocompatibility complex-restricted cytotoxicity of foreign target cells. The "gold standard" assay for NK cell activity has been the chromium release assay. This method is not easily performed in the clinical laboratory because of difficulties with disposal of radioactive and hazardous materials, short reagent half-lives, expense, and difficulties with assay standardization. We describe a flow cytometric assay for the clinical measurement of NK cell activity. This study compared the chromium release assay and the flow cytometric assay by using clinically relevant specimens. There were no significant differences between the two assays in the measurement of lytic activity for 17 peripheral blood specimens or in reproducibility in repeated samplings of healthy individuals. We also established a normal range of values for NK activity in healthy adults and identified a small cluster of individuals who have exceptionally high or low levels of NK activity. The flow cytometric assay was validated by testing specimens from subjects expected to have abnormally low levels of NK activity (pregnant women) and specimens from healthy individuals in whom the activity of NK cells was enhanced by exposure to interleukin-2 or alpha interferon. Treatment with these agents was associated with a significant increase in NK activity. These results confirm and extend those of others, showing that the flow cytometric assay is a viable alternative to the chromium release assay for measuring NK cell activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705672      PMCID: PMC170335          DOI: 10.1128/cdli.3.3.295-300.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

1.  Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells.

Authors:  N Imamura; Y Kusunoki; K Kawa-Ha; K Yumura; J Hara; K Oda; K Abe; H Dohy; T Inada; H Kajihara
Journal:  Br J Haematol       Date:  1990-05       Impact factor: 6.998

2.  Cytolytic activity of human natural killer cell subpopulations isolated by four-color immunofluorescence flow cytometric cell sorting.

Authors:  E F Srour; T Leemhuis; L Jenski; R Redmond; J Jansen
Journal:  Cytometry       Date:  1990

3.  Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.

Authors:  R R Herberman; J R Ortaldo; G D Bonnard
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

4.  Persistently low natural killer cell activity in normal adults: immunological, hormonal and mood correlates.

Authors:  S M Levy; R B Herberman; A Simons; T Whiteside; J Lee; R McDonald; M Beadle
Journal:  Nat Immun Cell Growth Regul       Date:  1989

5.  Flow cytometry evaluation of cell-mediated cytotoxicity.

Authors:  D Zarcone; A B Tilden; G Cloud; H M Friedman; A Landay; C E Grossi
Journal:  J Immunol Methods       Date:  1986-11-20       Impact factor: 2.303

6.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

7.  Characteristics and uses of natural killer cells.

Authors:  T Hercend; R E Schmidt
Journal:  Immunol Today       Date:  1988-10

8.  Circulating lymphocyte subpopulations in pregnancy: a longitudinal study.

Authors:  D F Tallon; D J Corcoran; E M O'Dwyer; J F Greally
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

9.  Comparative studies of human FcRIII-positive and negative natural killer cells.

Authors:  A Nagler; L L Lanier; S Cwirla; J H Phillips
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

10.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more
  16 in total

1.  Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer.

Authors:  Carolyn B Coulam; Roumen G Roussev
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

2.  A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.

Authors:  Fadi Kandarian; Gemalene M Sunga; Diana Arango-Saenz; Maura Rossetti
Journal:  J Vis Exp       Date:  2017-08-09       Impact factor: 1.355

3.  Immunological changes in different patient populations with chronic hepatitis C virus infection.

Authors:  Laszlo Szereday; Matyas Meggyes; Melinda Halasz; Julia Szekeres-Bartho; Alajos Par; Gabriella Par
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

4.  Objective and subjective breast cancer risk: relationships with natural killer cell activity and psychological distress in healthy women.

Authors:  Na-Jin Park; Duck-Hee Kang; Michael T Weaver
Journal:  Cancer Nurs       Date:  2010 Nov-Dec       Impact factor: 2.592

5.  Hemacytotoxicity and natural killer lytic index: New parameters to evaluate natural killer cell immunity for clinical use in cancer.

Authors:  Hyung Gun Maeng; Su Jin Lee; Yun A Lee; Hye Jeong Lee; Young Joo Kim; Jong Kyun Lee; Jae Cheol Kim; Joungbum Choi
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

6.  The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth.

Authors:  Amanda S Büchau; Shin Morizane; Janet Trowbridge; Jürgen Schauber; Paul Kotol; Jack D Bui; Richard L Gallo
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

7.  Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.

Authors:  Julian J Lum; David J Schnepple; Zilin Nie; Jaime Sanchez-Dardon; Georgina L Mbisa; Jennifer Mihowich; Nanci Hawley; Shanil Narayan; John E Kim; David H Lynch; Andrew D Badley
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome.

Authors:  Chi-Bun Chan; Michiyo Abe; Noriyoshi Hashimoto; Chunhai Hao; Ifor R Williams; Xia Liu; Shinji Nakao; Akitsugu Yamamoto; Chengyun Zheng; Jan-Inge Henter; Marie Meeths; Magnus Nordenskjold; Shi-Yong Li; Ikuko Hara-Nishimura; Masahide Asano; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-23       Impact factor: 11.205

9.  Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.

Authors:  Satiro Nakamura De Oliveira; Christine Ryan; Francesca Giannoni; Cinnamon L Hardee; Irena Tremcinska; Behrod Katebian; Jennifer Wherley; Arineh Sahaghian; Andy Tu; Tristan Grogan; David Elashoff; Laurence J N Cooper; Roger P Hollis; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2013-10       Impact factor: 5.695

10.  Skin TLR7 triggering promotes accumulation of respiratory dendritic cells and natural killer cells.

Authors:  Holger Hackstein; Nicole Hagel; Angela Knoche; Sabine Kranz; Jürgen Lohmeyer; Werner von Wulffen; Olivia Kershaw; Achim D Gruber; Gregor Bein; Nelli Baal
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.